Why EFCC is Investigating Saraki — Magu — Nigerian Pilot News
Connect with us

News

Why EFCC is Investigating Saraki — Magu

Published

on

Magu laments, says corrupt politicians outsmarting EFCC

Acting Chairman of the Economic and Financial Crimes Commission, EFCC, Ibrahim Magu, yesterday, declared that the investigation of the Senate President, Bukola Saraki is not based on personal motive.
He said the commission only invites people it suspects of corruption-related crimes.
Mr. Magu spoke yesterday with journalists after receiving an award at the commission’s headquarters in Abuja.
The Outstanding Leadership in Public Service Award was presented to him by Euro Knowledge Group.
When asked why the EFCC is reopening investigations into old cases against Saraki, the EFCC chairman said ‘‘no it is not personal, we are not after anybody. His case is not different from other individuals that are being investigated.”
He said the commission does not witch hunt any government official irrespective of their political background.
‘‘The EFCC does not pursue people who do not have corruption cases. If you are not corrupt, we do not invite you. If you are not a 419 or internet fraudster, we would never invite you.
‘‘We do our homework very well. Sometimes we conduct our investigations for up to six months; we have been investigating people for more than five years.
‘‘Corruption is a national disaster; every Nigerian should fight corruption, whether you are in Nigeria or outside the country. You remove corruption, you eradicate disaster. Banditry and Boko Haram, the root is corruption,” he said.
The EFCC had on Sunday marked some properties at 15a, 15b and 17 MacDonald Road, Ikoyi, Lagos allegedly belonging to Mr Saraki.
Reacting through a statement on Sunday by his media aide, Yusuph Olaniyonu, Saraki said the agency was only investigating what it had once probed.
He tagged the agency as being ‘mischievous.’

122 total views, 122 views today

Continue Reading
Advertisement
Loading...
Click to comment
Advertisement
Advertisement
Loading...

Most Read